The U.S. Compounding Pharmacies Market Growth Accelerated by Expanding Therapeutic Areas
The compounding pharmacies market in the U.S. involves the preparation of customized medication as per the needs and demands of the patients. Compounding pharmacies produce medications for those who cannot use commercially available drugs owing to allergies or inability to swallow pills. The growing geriatric population suffering from chronic ailments driving the need for compounded formulations.
The U.S.
Compounding Pharmacies Market is estimated to be valued at US$ 5072.19 Mn in
2023 and is expected to exhibit a CAGR
of 5.9% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
The expanding therapeutic areas is one of the key trends driving the growth of
the U.S. compounding pharmacies market. Compounded medications are witnessing
increased demand for various therapeutic applications including pain
management, hormone replacement therapy, dermatology, oncology etc. As per
data, over 60% of compounded drugs prepared by pharmacies in the U.S. belonged
to pain management, hormone replacement and dermatology categories in 2022. The
increasing prevalence of chronic pain conditions and rise in hormonal
deficiencies in aging population in the country is contributing to the
increased demand for compounded drugs in these therapeutic areas. Moreover,
compounded drugs are gaining traction for applications in pediatric and
veterinary medicine as well which is further supporting the market growth during
the forecast period.
Segment Analysis
The U.S.
Compounding Pharmacies market size is dominated by compounded oral
medications sub-segment, accounting for around 60% share of the overall market.
This is due to the growing demand for compounded oral solids and liquids that
can be customized as per medical needs. Compounded topical medications
sub-segment remains the second largest segment and is expected to witness
steady growth during the forecast period.
Key Takeaways
The U.S. Compounding Pharmacies Market is
estimated to be valued at US$ 5072.19 Mn in 2023 and is expected to exhibit a
CAGR of 5.9% over the forecast period 2023 to 2030.
Regional analysis: The Western
region dominates the U.S. Compounding Pharmacies market with around 35% value share.
This is attributed to rising geriatric population and increasing prevalence of
chronic conditions in states like California that require customized
medications frequently. Southeast region is poised to witness highest growth
during the forecast period owing to expansion of healthcare facilities and
insurance coverage in states like Florida.
Key players: Key players operating
in the U.S. Compounding Pharmacies Market are PharMEDium, Institutional
Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacy, and
Lorraine's Pharmacy. These players are focusing on expanding their production
facilities and offerings to cater to the rising demand for compounded
medications. They are also adopting innovative techniques like 3D printing for
compounding to improve efficiency and offer specialized products.
Get
more insights on this topic: https://www.newsstatix.com/u-s-compounding-pharmacies-market-share-and-opportunity-analysis/
Explore
more information on this topic, Please visit: https://masstamilan.in/pcb-design-software-essential-tools-for-electronics-product-development/
Comments
Post a Comment